Jamjoom Pharma Factory

Jamjoom Pharma Factory’s net income grew 30.1% y-o-y to SAR 463.8 mn in 2025 — beating Bloomberg analysts’ expectations of SAR 457.5 mn — a Tadawul disclosure showed. Revenue also rose 13.8% y-o-y to SAR 1.5 bn on stronger demand, solid volume growth across KSA, the Gulf, Iraq, and Egypt, new launches, and better supply chain execution.

Dividends: Jamjoom’s board greenlit the distribution of SAR 140 mn in interim dividends for 2H 2025 at SAR 2 apiece starting 15 March, according to a separate bourse filing. This brings the total 2025 dividend payout to SAR 280 mn, following 1H 2025’s SAR 140 mn.

Saudi German Health

Saudi German Health saw its net income jump 7.1% y-o-y to SAR 301.9 mn last year, driven by growth in the total number of inpatient and outpatient visits, greater bed capacity, and a one-off contract awarded by the Health Ministry, according to a disclosure to Tadawul. Meanwhile, revenue rose 7.6% y-o-y to SAR 3.1 bn.

Dividends:The company’s board recommended the distribution of SAR 46 mn in dividends at SAR 0.5 per share, according to a separate disclosure.

Marafiq

The Power and Water Utility Company for Jubail and Yanbu (Marafiq) saw its net income increase 25x y-o-y in 2025 to SAR 449.4 mn, according to a disclosure to Tadawul. The company said the jump came on the back of higher revenues from its subsidiary Tawreed, rising water and gas revenues, and recording a provision for expected credit loss. Meanwhile, revenues edged up 0.9% y-o-y to roughly SAR 6.9 bn.

Dividends:Marafiq’s board of directors announced a dividend payout of SAR 450 mn for 2H 2025 at SAR 1.8 per share, according to a separate disclosure.

Tags: